Errata: Amendments to the Combined Executive Summary and the main report for the Evidence Review This attachment contains information on minor changes to the content of the Combined Executive Summary and the Renewal Evid

First Page		Document Content
Date: 2015-02-10 23:18:59 Gynaecological cancer Carcinogens Human papillomavirus Cervical screening Medical device Therapeutic Goods Administration Hologic Papillomaviridae Cobas Medicine Oncology Papillomavirus		Errata: Amendments to the Combined Executive Summary and the main report for the Evidence Review This attachment contains information on minor changes to the content of the Combined Executive Summary and the Renewal Evid Add to Reading List Source URL: www.cervicalscreen.health.gov.au Download Document from Source Website File Size: 47,27 KB Share Document on Facebook

	IMDRF Presentation: Jurisdictional update - Australia DocID: 1paZs - View Document
	Appendix B.10 Department of Health Summary Health reported 59 measures during the year, with a total net regulatory saving of $96.8 million per year. In 2015, the Health Portfolio continued to contribute strongly to th DocID: 1oUqD - View Document
	2015 Annual Red Tape Reduction Report Appendix B.10 - Department of Health DocID: 1oH8C - View Document
	The Australian and New Zealand Medical Device Incident Report Investigation Scheme What is it? The Scheme is a joint venture between the Australian Therapeutic Goods Administration and Medsafe, the New Zealand Medicines DocID: 1lTjb - View Document
	AUSTRALIAN GOVERNMENT WARNINGS & OTHER ACTIONS ON PSYCHOTROPIC DRUGS The Therapeutic Goods Administration (TGA) is Australia’s drug regulatory agency. They are responsible for authorising the sale of drugs and medical DocID: 1jYXQ - View Document